Acute-on-Chronic Liver Failure: Pathophysiological Basis of Therapeutic Options
Top Cited Papers
- 27 February 2002
- journal article
- review article
- Published by S. Karger AG in Blood Purification
- Vol. 20 (3) , 252-261
- https://doi.org/10.1159/000047017
Abstract
The vast majority of patients that are referred to a specialist hepatological centre suffer from acute deterioration of their chronic liver disease. Yet, this entity of acute-on-chronic liver failure remains poorly defined. With the emergence of newer liver support strategies, it has become necessary to define this entity, its pathophysiology and the short- and long-term prognosis. This review focusses upon how a precipitant such as an episode of gastrointestinal bleeding or sepsis may start a cascade of events that culminate in end-organ dysfunction and liver failure. We briefly review the pathophysiological basis of the therapeutic modalities that are available. Our current strategy for the management of liver failure involves supportive therapy for the end-organs with the hope that liver function would recover if sufficient time for such a recovery is allowed. Because liver failure, whether of the acute or acute-on-chronic variety, is potentially reversible, the stage is set for the application of newer liver-support strategies to enhance the recovery process.Keywords
This publication has 10 references indexed in Scilit:
- Altered Peripheral Vascular Responses to Exogenous and Endogenous Endothelin–1 in Patients With Well–Compensated CirrhosisHepatology, 2001
- The systemic inflammatory response syndrome in acute liver failureHepatology, 2000
- Compartmentalised inducible nitric-oxide synthase activity in septic shockThe Lancet, 2000
- Xenografts and RetrovirusesScience, 1999
- Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trialJournal of Hepatology, 1998
- Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndromeThe Lancet, 1997
- Differential Expression of iNOS and cNOS mRNA in Human Vascular Smooth Muscle Cells and Endothelial Cells under Normal and Inflammatory ConditionsBiochemical and Biophysical Research Communications, 1993
- Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthasesFEBS Letters, 1991
- Branched-Chain Amino Acid MetabolismAnnual Review of Nutrition, 1984
- Down regulation of striatal dopamine receptors in experimental hepatic encephalopathyLife Sciences, 1983